These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 32885440

  • 1. Effects of probiotic and prebiotic supplementation on metabolic parameters, liver aminotransferases, and systemic inflammation in nonalcoholic fatty liver disease: A randomized clinical trial.
    Behrouz V, Aryaeian N, Zahedi MJ, Jazayeri S.
    J Food Sci; 2020 Oct; 85(10):3611-3617. PubMed ID: 32885440
    [Abstract] [Full Text] [Related]

  • 2. Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Loman BR, Hernández-Saavedra D, An R, Rector RS.
    Nutr Rev; 2018 Nov 01; 76(11):822-839. PubMed ID: 30113661
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Functions of Coenzyme Q10 Supplementation on Liver Enzymes, Markers of Systemic Inflammation, and Adipokines in Patients Affected by Nonalcoholic Fatty Liver Disease: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Farsi F, Mohammadshahi M, Alavinejad P, Rezazadeh A, Zarei M, Engali KA.
    J Am Coll Nutr; 2016 Nov 01; 35(4):346-53. PubMed ID: 26156412
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of sour tea supplementation on liver enzymes, lipid profile, blood pressure, and antioxidant status in patients with non-alcoholic fatty liver disease: A double-blind randomized controlled clinical trial.
    Izadi F, Farrokhzad A, Tamizifar B, Tarrahi MJ, Entezari MH.
    Phytother Res; 2021 Jan 01; 35(1):477-485. PubMed ID: 32909326
    [Abstract] [Full Text] [Related]

  • 8. Effect of Portulaca Oleracea (purslane) extract on liver enzymes, lipid profile, and glycemic status in nonalcoholic fatty liver disease: A randomized, double-blind clinical trial.
    Darvish Damavandi R, Shidfar F, Najafi M, Janani L, Masoodi M, Akbari-Fakhrabadi M, Dehnad A.
    Phytother Res; 2021 Jun 01; 35(6):3145-3156. PubMed ID: 33880813
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of garlic powder supplementation on hepatic steatosis, liver enzymes and lipid profile in patients with non-alcoholic fatty liver disease: a double-blind randomised controlled clinical trial.
    Sangouni AA, Mohammad Hosseini Azar MR, Alizadeh M.
    Br J Nutr; 2020 Aug 28; 124(4):450-456. PubMed ID: 32312333
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The Relationship between Prebiotic Supplementation and Anthropometric and Biochemical Parameters in Patients with NAFLD-A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Stachowska E, Portincasa P, Jamioł-Milc D, Maciejewska-Markiewicz D, Skonieczna-Żydecka K.
    Nutrients; 2020 Nov 11; 12(11):. PubMed ID: 33187278
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD.
    Hadi A, Mohammadi H, Miraghajani M, Ghaedi E.
    Crit Rev Food Sci Nutr; 2019 Nov 11; 59(15):2494-2505. PubMed ID: 29584449
    [Abstract] [Full Text] [Related]

  • 14. The promising role of probiotic and synbiotic therapy in aminotransferase levels and inflammatory markers in patients with nonalcoholic fatty liver disease - a systematic review and meta-analysis.
    Khan MY, Mihali AB, Rawala MS, Aslam A, Siddiqui WJ.
    Eur J Gastroenterol Hepatol; 2019 Jun 11; 31(6):703-715. PubMed ID: 31009401
    [Abstract] [Full Text] [Related]

  • 15. Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: A randomized clinical trial.
    Kazemi A, Noorbala AA, Azam K, Eskandari MH, Djafarian K.
    Clin Nutr; 2019 Apr 11; 38(2):522-528. PubMed ID: 29731182
    [Abstract] [Full Text] [Related]

  • 16. Probiotic mixture improves fatty liver disease by virtue of its action on lipid profiles, leptin, and inflammatory biomarkers.
    Al-Muzafar HM, Amin KA.
    BMC Complement Altern Med; 2017 Jan 13; 17(1):43. PubMed ID: 28086768
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of Calorie-Restricted Diet and Resveratrol Supplementation on Anthropometric Indices, Metabolic Parameters, and Serum Sirtuin-1 Levels in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial.
    Asghari S, Asghari-Jafarabadi M, Somi MH, Ghavami SM, Rafraf M.
    J Am Coll Nutr; 2018 Jan 13; 37(3):223-233. PubMed ID: 29313746
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Disease.
    Ahn SB, Jun DW, Kang BK, Lim JH, Lim S, Chung MJ.
    Sci Rep; 2019 Apr 05; 9(1):5688. PubMed ID: 30952918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.